Evidence map›Paper›PMID 28967519›Full record

ArticleVaccine2017

Evaluation of the innate immune responses to influenza and live-attenuated influenza vaccine infection in primary differentiated human nasal epithelial cells.

Adriana Forero, Katherine Fenstermacher, Nicholas Wohlgemuth, Andrew Nishida, Victoria Carter, Elise A Smith, Xinxia Peng, Melissa Hayes, Doreen Francis, John Treanor and 5 more

Abstract read
In one paragraph

Article in Vaccine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 35 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Seasonal PMParticle and fibre toxicology · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. 2019-20 H1N1 clade A5a.1 viruses have betterbioRxiv : the preprint server for biology · 2023
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 1 country.

Adriana ForeroDepartment of Microbiology, University of Washington, Seattle, WA, USA.
Katherine FenstermacherW. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA.
Nicholas WohlgemuthW. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA.
Andrew NishidaDepartment of Microbiology, University of Washington, Seattle, WA, USA.
Victoria CarterDepartment of Microbiology, University of Washington, Seattle, WA, USA.
Elise A SmithDepartment of Microbiology, University of Washington, Seattle, WA, USA.
Xinxia PengDepartment of Microbiology, University of Washington, Seattle, WA, USA.
Melissa HayesW. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA.
Doreen FrancisDepartment of Internal Medicine, University of Rochester, School of Medicine and Dentistry, Rochester, New York, USA.
John TreanorDepartment of Internal Medicine, University of Rochester, School of Medicine and Dentistry, Rochester, New York, USA.
Juliet MorrisonDepartment of Microbiology, University of Washington, Seattle, WA, USA.
Sabra L KleinW. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA.
Andrew LaneDepartment of Otolaryngology-Head and Neck Surgery, Johns Hopkins University, School of Medicine, Baltimore, MD, USA.
Michael G KatzeDepartment of Microbiology, University of Washington, Seattle, WA, USA; Washington National Primate Research Center, University of Washington, Seattle, WA, USA.
Andrew PekoszW. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA; Department of Environmental Health Sciences, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA. Electronic address: apekosz1@jhu.edu.
University of Washington · USJohns Hopkins University · USUniversity of Rochester · USJohns Hopkins Medicine · US

Funding

Washington National Primate Research CenterP51OD010425 · OD · UNIVERSITY OF WASHINGTON · PI Mari Ostendorf · 2012 to 2026
$201.8M
Training: Molecular & Cellular Bases of Infectious DiseasesT32AI007417 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Arturo Casadevall · 1994 to 2026
$11.9M
Influenza A Virus Infection of Human Nasal Epithelial CellsR01AI097417 · NIAID · JOHNS HOPKINS UNIVERSITY · PI PEKOSZ, ANDREW S. · 2012 to 2015
$1.7M
NIAID NIH HHS HHSN272201400005CNIAID NIH HHS HHSN272201400007CNIAID NIH HHS R01 AI097417NIAID NIH HHS T32 AI007417NIH HHS P51 OD010425
6 · The paper itself

Abstract

The host innate immune response to influenza virus is a key determinant of pathogenic outcomes and long-term protective immune responses against subsequent exposures. Here, we present a direct contrast of the host responses in primary differentiated human nasal epithelial cell (hNEC) cultures following infection with either a seasonal H3N2 influenza virus (WT) or the antigenically-matched live-attenuated vaccine (LAIV) strain. Comparison of the transcriptional profiles obtained 24 and 36h post-infection showed that the magnitude of gene expression was greater in LAIV infected relative to that observed in WT infected hNEC cultures. Functional enrichment analysis revealed that the antiviral and inflammatory responses were largely driven by type III IFN induction in both WT and LAIV infected cells. However, the enrichment of biological pathways involved in the recruitment of mononuclear leukocytes, antigen-presenting cells, and T lymphocytes was uniquely observed in LAIV infected cells. These observations were reflective of the host innate immune responses observed in individuals acutely infected with influenza viruses. These findings indicate that cell-intrinsic type III IFN-mediated innate immune responses in the nasal epithelium are not only crucial for viral clearance and attenuation, but may also play an important role in the induction of protective immune responses with live-attenuated vaccines.

Indexed as

AnimalsAntigen-Presenting CellsCell LineDogsEpithelial CellsHumansImmunity, InnateInfluenza A Virus, H3N2 SubtypeInfluenza, HumanInfluenza VaccinesLeukocytes, MononuclearMadin Darby Canine Kidney CellsNasal MucosaT-LymphocytesVaccines, AttenuatedInfluenza VaccinesVaccines, AttenuatedEpithelial cellsHost responseInflammationInfluenza virusInterferonLive-attenuated vaccine

Identifiers

PMID28967519
PMCPMC5647870
OpenAlexW2760475801

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.